Page 2 - Aaron Mann News Today

10.01.2022 - ORLANDO, FL / ACCESSWIRE / January 10, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the signing of a feasibility agreement with Kindeva Drug Delivery to develop Nutribands lead product, AVERSA™ Fentanyl, based on its ... Seite 1

Sharing patient data generated from clinical trials has the power to transform the trial process itself, improving the patient experience and...

Dr. Khankari brings 28 years of global experience in the pharmaceutical and drug delivery sectors.


News | March 17, 2021 Sandoz In-Licenses Brand And Authorized Generic Of Respiratory Medicine Proventil® HFA (Albuterol Sulfate) Inhalation Aerosol From Kindeva Drug Delivery, With Immediate Generic Availability In US Source: Kindeva Drug Delivery Albuterol sulfate is used to treat or prevent bronchospasm in patients four years and older with reversible obstructive airway disease, such as asthma, and to prevent exercise-induced bronchospasm 1 Immediate launch of our au...

Global drug delivery company expands operations at Charnwood Campus Global contract development and manufacturing organisation (CDMO) Kindeva Drug Delivery has expanded its operations at Loughborough’s life sciences hub Charnwood Campus, in a deal expected to support Kindeva’s continued growth in the UK. The US-headquartered company will take over a state-of-the-art research and development facility at Charnwood Campus, and a further 20,000 square feet of office space at the site. Formerly...

News | March 8, 2021 Viatris Inc. And Kindeva Drug Delivery Announce FDA Tentative Approval Of The First Abbreviated New Drug Application Generic Version Of Symbicort® (Budesonide/Formoterol Fumarate Dihydrate) Inhalation Aerosol Source: Kindeva Drug Delivery Milestone reinforces Viatris commitment to complex products and innovative solutions to help increase patient access PITTSBURGH and ST. PAUL, Minn., March 8, 2021 — Viatris Inc. (NASDAQ: VTRS) and Kindev...

PITTSBURGH and ST. PAUL, Minn., March 8, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted